{"title": "Effect of high dose vitamin C on Epstein-Barr viral infection", "author": "Nina MIkirova; Ronald Hunninghake", "url": "https://medscimonit.com/abstract/index/idArt/890423", "hostname": "medscimonit.com", "description": "Background:Many natural compounds were tested for the ability to suppress viral replication. The present manuscript details an analysis of high dose vitamin C therapy on patients with EBV infection. Material andMethods:The data were obtained from the patient history database at the Riordan Clinic. Among people in our database who were treated with intravenous vitamin C (7.5 g to 50 g infusions) between 1997 and 2006, 178 patients showed elevated levels of EBV EA IgG (range 25 to 211 AU) and 40 showed elevated levels of EBV VCA IgM (range 25 to 140 AU). Most of these patients had a diagnosis of chronic fatigue syndrome, with the rest being diagnosed as having mononucleosis, fatigue, or EBV infection. Results:Our data provide evidence that high dose intravenous vitamin C therapy has a positive effect on disease duration and reduction of viral antibody levels. Plasma levels of ascorbic acid and vitamin D were correlated with levels of antibodies to EBV. We found an inverse correlation between EBV VCA IgM and vitamin C in plasma in patients with mononucleosis and CFS meaning that patients with high levels of vitamin C tended to have lower levels of antigens in the acute state of disease. In addition, a relation was found between vitamin D levels and EBV EA IgG with lower levels of EBV early antigen IgG for higher levels of vitamin D. Conclusions:The clinical study of ascorbic acid and EBV infection showed the reduction in EBV EA IgG and EBV VCA IgM antibody levels over time during IVC therapy that is consistent with observations from the literature that millimolar levels of ascorbate hinder viral infection and replication in vitro.", "sitename": "Medical Science Monitor", "date": "2014-05-03", "cleaned_text": "paper Nina MIkirovaACDE, Ronald HunninghakeA [ Effect of high dose vitamin C on Epstein-Barr viral infection](javascript:void(0)) DOI: 10.12659/MSM.890423 Med Sci Monit 2014; 20:725-732 Abstract BACKGROUND: Many natural compounds were tested for the ability to suppress viral replication. The present manuscript details an analysis of high dose vitamin C therapy on patients with EBV infection. MATERIAL AND METHODS: The data were obtained from the patient history database at the Riordan Clinic. Among people in our database who were treated with intravenous vitamin C (7.5 g to 50 g infusions) between 1997 and 2006, 178 patients showed elevated levels of EBV EA IgG (range 25 to 211 AU) and 40 showed elevated levels of EBV VCA IgM (range 25 to 140 AU). Most of these patients had a diagnosis of chronic fatigue syndrome, with the rest being diagnosed as having mononucleosis, fatigue, or EBV infection. RESULTS: Our data provide evidence that high dose intravenous vitamin C therapy has a positive effect on disease duration and reduction of viral antibody levels. Plasma levels of ascorbic acid and vitamin D were correlated with levels of antibodies to EBV. We found an inverse correlation between EBV VCA IgM and vitamin C in plasma in patients with mononucleosis and CFS meaning that patients with high levels of vitamin C tended to have lower levels of antigens in the acute state of disease. In addition, a relation was found between vitamin D levels and EBV EA IgG with lower levels of EBV early antigen IgG for higher levels of vitamin D. CONCLUSIONS: The clinical study of ascorbic acid and EBV infection showed the reduction in EBV EA IgG and EBV VCA IgM antibody levels over time during IVC therapy that is consistent with observations from the literature that millimolar levels of ascorbate hinder viral infection and replication in vitro. Keywords: Ascorbic Acid - therapeutic use, Antigens, Viral - immunology, Antibodies, Viral - blood, Databases, Factual, Dose-Response Relationship, Drug, Epstein-Barr Virus Infections - virology, Herpesvirus 4, Human - physiology, Lymphocytes - immunology Editorial 01 September 2023 : Editorial [Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Sep 2023 : Clinical Research [The Impact of Sedentary Behavior on Renal Function Decline in 132,123 Middle Aged and Older Adults: A Natio...](https://medscimonit.com/abstract/index/idArt/941111) Med Sci Monit In Press; DOI: 10.12659/MSM.941111 06 Sep 2023 : Clinical Research [Predicting Survival Outcomes in Post-Cardiac Arrest Syndrome: The Impact of Combined Sequential Sci Monit In Press; DOI: 10.12659/MSM.942119 06 Sep 2023 : Laboratory Research [Comparative Analysis of Properties in Chairside Silicone Denture Liners versus 06 Sep 2023 : Clinical Research [Impact of Mental State on the Severity of Psoriasis Symptoms: A Study on Patient's Emotional Well-Being](https://medscimonit.com/abstract/index/idArt/941636) Med Sci Monit In Press; DOI: 10.12659/MSM.941636 Most Viewed Current Articles 13 Nov 2021 : Clinical Research [Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...](https://medscimonit.com/abstract/full/idArt/932788) DOI :10.12659/MSM.932788 Med Sci Monit 2021; 27:e932788 30 Dec 2021 : Clinical Research [Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...](https://medscimonit.com/abstract/full/idArt/935379) DOI :10.12659/MSM.935379 Med Sci Monit 2021; 27:e935379 08 Mar 2022 : Review article [A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...](https://medscimonit.com/abstract/full/idArt/936292) 2022; 28:e936292 01 Jan 2022 : Editorial [Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized "}